Tokyo Tape
Sign in
← Gakken Holdings

Quarterly report · Q2

9470.TEDINET S100TE39
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥93.5bn2023-10-01 → 2024-03-31Cons.Net sales
Revenue¥164.1bn2022-10-01 → 2023-09-30Cons.Net sales (5-year summary)
Revenue¥81.2bn2022-10-01 → 2023-03-31Cons.Net sales
Operating income¥5.1bn2023-10-01 → 2024-03-31Cons.Operating income
Operating income¥3.2bn2022-10-01 → 2023-03-31Cons.Operating income
Ordinary income¥5.2bn2023-10-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥6.5bn2022-10-01 → 2023-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥3.3bn2022-10-01 → 2023-03-31Cons.Ordinary income
Profit before tax¥3.8bn2023-10-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥2.6bn2022-10-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥1.8bn2023-10-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.2bn2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-10-01 → 2024-03-31Cons.Profit loss
Net income¥1.3bn2022-10-01 → 2023-03-31Cons.Profit loss
Total assets¥139.4bnat 2024-03-31Cons.Assets
Total assets¥136.3bnat 2023-09-30Cons.Assets
Total assets¥132.2bnat 2023-03-31Cons.Total assets (5-year summary)
Total liabilities¥84.7bnat 2024-03-31Cons.Liabilities
Total liabilities¥81.3bnat 2023-09-30Cons.Liabilities
Net assets / equity¥54.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥55.0bnat 2023-09-30Cons.Net assets
Net assets / equity¥50.6bnat 2023-03-31Cons.Net assets (5-year summary)
Cash and deposits¥23.8bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥20.8bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥22.0bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥19.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥24.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.7bnat 2022-09-30dCons.Cash and cash equivalents
Operating cash flow¥1.6bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥5.5bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥167m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥3.9bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥4.8bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.1bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.5bn2023-10-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥6.2bn2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.4bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥41.192023-10-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.682024-01-01 → 2024-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥72.512022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.152022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.852023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥40.872023-10-01 → 2024-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥71.92022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.92022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio37.5%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-10-01 → 2024-03-31¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-10-01 → 2024-03-31¥3.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-10-01 → 2024-03-31¥4.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-10-01 → 2024-03-31¥282m
Reconciling Itemsreconcilingrevenue2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2024-03-31−¥4.3bn
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-03-31−¥923m
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2023-10-01 → 2024-03-31¥48.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2023-10-01 → 2024-03-31¥48.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥126m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2023-10-01 → 2024-03-31¥3.7bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2023-10-01 → 2024-03-31¥42.2bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2023-10-01 → 2024-03-31¥42.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2023-10-01 → 2024-03-31¥27m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2023-10-01 → 2024-03-31¥2.1bn
—segment totalrevenue2023-10-01 → 2024-03-31¥90.5bn
—segment totalrevenue external2023-10-01 → 2024-03-31¥90.3bn
—segment totalrevenue intersegment2023-10-01 → 2024-03-31¥153m
—segment totalsegment profit2023-10-01 → 2024-03-31¥5.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-03-31¥97.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-03-31¥93.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-10-01 → 2024-03-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-03-31¥6.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-10-01 → 2023-03-31¥7.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-10-01 → 2023-03-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-10-01 → 2023-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-10-01 → 2023-03-31¥294m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥1.0bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2022-10-01 → 2023-03-31¥40.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2022-10-01 → 2023-03-31¥40.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥116m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2022-10-01 → 2023-03-31¥2.6bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥42m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2022-10-01 → 2023-03-31¥1.4bn
—segment totalrevenue2022-10-01 → 2023-03-31¥78.4bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥78.3bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥158m
—segment totalsegment profit2022-10-01 → 2023-03-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥86.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥81.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-10-01 → 2023-03-31¥4.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 536
ItemContextValueUnit
Selling general and administrative expensesPrior1YTDDuration20381000000JPY
Selling general and administrative expensesCurrentYTDDuration21353000000JPY
Operating incomePrior1YTDDuration3224000000JPY
Operating incomeCurrentYTDDuration5141000000JPY
Interest income noiPrior1YTDDuration4000000JPY
Interest income noiCurrentYTDDuration13000000JPY
Dividends income noiPrior1YTDDuration55000000JPY
Dividends income noiCurrentYTDDuration61000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration180000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration90000000JPY
Other noiPrior1YTDDuration126000000JPY
Other noiCurrentYTDDuration135000000JPY
Non operating incomePrior1YTDDuration367000000JPY
Non operating incomeCurrentYTDDuration301000000JPY
Interest expenses noePrior1YTDDuration91000000JPY
Interest expenses noeCurrentYTDDuration156000000JPY
Other noePrior1YTDDuration234000000JPY
Other noeCurrentYTDDuration132000000JPY
Non operating expensesPrior1YTDDuration325000000JPY
Non operating expensesCurrentYTDDuration288000000JPY
Ordinary incomePrior1YTDDuration3266000000JPY
Ordinary incomeCurrentYTDDuration5154000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration4000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Gain on sales of investment securities eiPrior1YTDDuration55000000JPY
Gain on sales of investment securities eiCurrentYTDDuration82000000JPY
Other eiPrior1YTDDuration8000000JPY
Other eiCurrentYTDDuration8000000JPY
Extraordinary incomePrior1YTDDuration68000000JPY
Extraordinary incomeCurrentYTDDuration91000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration0JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration173000000JPY
Impairment loss elPrior1YTDDuration1000000JPY
Impairment loss elCurrentYTDDuration75000000JPY
Loss on sales of investment securities elPrior1YTDDuration－JPY
Loss on sales of investment securities elCurrentYTDDuration1085000000JPY
Loss on valuation of investment securities elPrior1YTDDuration682000000JPY
Loss on valuation of investment securities elCurrentYTDDuration17000000JPY
Other elPrior1YTDDuration58000000JPY
Other elCurrentYTDDuration60000000JPY
Extraordinary lossPrior1YTDDuration743000000JPY
Extraordinary lossCurrentYTDDuration1412000000JPY
Income before income taxesPrior1YTDDuration2591000000JPY
Income before income taxesCurrentYTDDuration3834000000JPY
Income taxesPrior1YTDDuration1270000000JPY
Income taxesCurrentYTDDuration1927000000JPY
Profit lossPrior1YTDDuration1321000000JPY
Profit lossCurrentYTDDuration1906000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration82000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration133000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-10-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass